Basic Information
Basic information for LINC01203-223-13aa-2
Peptide Name LINC01203-223-13aa-2
Genome Position chrX:13375451-13375483,13377190-13377195[+]
Species Human
Peptide Sequence MLQSGSITLKKPL
Peptide Length 13
Unique No (LINC01203-204-13aa-3,LINC01203-205-13aa-2,LINC01203-206-13aa-4,LINC01203-207-13aa,LINC01203-208-13aa-2,LINC01203-209-13aa-3,LINC01203-210-13aa-1,LINC01203-211-13aa-1,LINC01203-212-13aa-2,LINC01203-213-13aa-1,LINC01203-214-13aa-1,LINC01203-215-13aa-1,LINC01203-216-13aa-4,LINC01203-218-13aa-2,LINC01203-219-13aa-2,LINC01203-220-13aa,LINC01203-221-13aa-3,LINC01203-222-13aa-4)
Grand Average of Hydropathicity 0.1692
Relative Molecular Mass 1631.96
Experimental Evidences no
lncRNA ID/Name ENSG00000226985;LINC01203
Transcript ID/Name ENST00000671651;LINC01203-223
Transcript Length 1358
Coding Ability 0.5184
DNA Sequence Corresponding to Peptide ATGTTGCAGTCTGGAAGCATCACTCTCAAAAAGCCATTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :